Wall Street is wrapping up 2025 on a high note. The S&P 500 is set to finish the year up 17%, and if you've been paying attention, you know who deserves most of the credit: the usual suspects in tech. Nvidia, Microsoft, Alphabet, and Amazon have absolutely dominated the headlines, and for good reason.

Big tech didn't just participate in this rally; it led the charge. The Nasdaq-100 Index climbed 19.6% year to date, while the S&P 500 Information Technology Sector surged 27%. Strong earnings and momentum in semiconductors and AI-related companies fueled the outperformance, making it one of the best years in recent memory for tech investors.

But here's the thing: success breeds skepticism, especially when valuations start looking stretched. The information technology sector now trades at a 26.6 forward P/E, one of the highest among S&P 500 sectors according to FactSet. And if you zoom in on the Nasdaq-100, things look even pricier. One estimate pegs the index's P/E ratio at approximately 34.15 as of Christmas Eve, well above its typical range over the past five years.

That's got Wall Street's attention. Concerns about overvaluation in the big AI stocks are pushing investors to explore the next wave of smaller, nimbler AI plays for 2026. The worry isn't just confined to the Magnificent Seven, either. The entire tech-heavy Nasdaq-100 is trading at valuations that would have seemed absurd just a few years ago.

The AI Spending Machine Keeps Humming

Let's be clear about what's driving these premium valuations: AI capital expenditure. The spending is absolutely massive. Goldman Sachs notes that hyperscalers deployed $106 billion in capex in Q3, up 75% year over year. Growth is expected to slow somewhat but remain elevated into 2026.

So what does this mean for the "overvalued tech" narrative? AI keeps those multiples elevated as long as investors believe two critical things. First, that the spending wave is durable and not a flash in the pan. Second, that the monetization curve will materialize in earnings sooner rather than later.

The real risk isn't that AI demand evaporates. It's that profits don't scale fast enough to justify the valuations. Pricing pressure, competition, or capex and margin drag could quickly turn "premium growth" into "priced for perfection." Analysts have already flagged how the AI spending spree is driving record tech debt issuance and straining some credit metrics.

Why Smaller AI Stocks Are Getting a Fresh Look

With the mega-caps looking expensive, investors are pivoting toward smaller artificial intelligence stocks. These companies are increasingly on Wall Street's radar as we head into 2026, and the logic is pretty straightforward.

"The mega-caps like NVIDIA and Microsoft are great for stable returns, but the math on a 10-bagger just doesn't work when you're already at a $3 trillion market cap," said Jenna Lofton, a market analyst at StockHitter.com. "Smaller AI companies (under $50 billion) can realistically grow from $10 billion to $100 billion if they execute well. That's where you get asymmetric upside."

These smaller players aren't trying to compete with Nvidia on chips. They're carving out their own niches. "They're solving specific infrastructure problems like networking (Arista), monitoring (Datadog), or enterprise AI deployment (Palantir)," Lofton said. "Once their products are integrated into a company's AI stack, the switching costs are massive."

So which smaller AI stocks make sense right now? Here are three that could climb significantly from current levels.

Three Small-Cap AI Stocks Worth Watching

Arista Networks (ANET). This Santa Clara, California-based networking company makes the gear that connects AI data centers. If you're building the infrastructure for AI, you need high-speed networking equipment, and that's where Arista comes in.

"AI-driven revenue is now 55% of their business, up from 35% last year," Lofton said. "When hyperscalers build data centers, they need Arista's 400G and 800G switches."

JP Morgan lists Arista as one of its top stocks for 2025, noting the company has a durable moat thanks to rising demand for cloud and AI networking services. The stock is up 18% in 2025, but the investment bank believes it has plenty of room to grow.

Innodata (INOD). This one doesn't get as much attention as the flashier AI names, but it plays a critical role in the ecosystem. "While everyone is betting on who will build the best AI model, Innodata is the company cleaning and engineering the data that feeds those models," said David Jaffee, a former investment banker and the founder of BestStockStrategy.com. "They are the 'picks and shovels' of the AI gold rush."

Here's what makes Innodata interesting: unlike 90% of small-cap AI stocks that are burning cash, this company is profitable, debt-free, and generating positive cash flow. That's rare in this space.

Plus, Innodata has secured contracts with major Big Tech firms to provide high-quality data annotation and reinforcement learning services. "In 2025, as the industry shifts from 'training' to 'accuracy,' Innodata's services are becoming non-negotiable for enterprise AI," Jaffee said. It's a legitimate business, not vaporware.

Recursion Pharmaceuticals (RXRX). This one's for investors interested in the intersection of AI and biotech. Recursion isn't just doing biology; it's digitizing it.

"If we boil it all down, Recursion Pharmaceuticals is using AI to create a map over the biology layer, almost like a software code," said James Richman, CEO of OTLEN, a health-tech company. "This allows them to identify drug candidates way faster than humanly possible."

Recursion represents a different kind of AI bet. "This stock is a classic example of how to use pattern recognition to attack and solve all of those inefficiencies of the FDA approval process," Richman added. If AI can meaningfully accelerate drug discovery, companies like Recursion could see explosive growth.

The Case for Pure-Play AI Exposure

The appeal of smaller AI stocks comes down to focus. "When you buy Microsoft or Google, your AI exposure is diluted by their massive legacy businesses," Jaffee noted. "A 100% gain in their AI division might only move the total stock price by 5%."

Small-cap AI stocks offer asymmetric leverage. "They're agile, unburdened by bureaucracy, and can pivot faster to fill niche market gaps," Jaffee notes. "The 'why' is simple: investors are looking for the next Nvidia before it becomes Nvidia."

Understanding the Downside Risk

Now for the reality check. Small-cap AI stocks aren't for the faint of heart. "The risk smaller stocks bring is high-stakes; you're either buying a lottery ticket or a future giant," Jaffee noted. "There's rarely a middle ground."

Investors must also accept the extreme volatility that comes with these names. "Even small caps that eventually become successful can lose 70% of their value during a bull market correction," Jaffee added. "This often shakes out retail investors right before the recovery. Larger capitalization stocks are generally less volatile and much easier to hold psychologically during market downturns."

That's the trade-off. You get exposure to potentially explosive growth, but you also sign up for stomach-churning volatility. If you can handle the swings and you believe AI infrastructure spending will continue driving growth across the ecosystem, smaller AI plays might deserve a spot in your portfolio for 2026. Just know what you're getting into.